ipsc
Cell therapyexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2023 (NCT05647213)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ipsc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07065409 | Phase 1 | May 26, 2025 | Huazhong University of Science and Technology |
| NCT06866600 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2025 | — |
| NCT06765564 | N/A | Mar 13, 2024 | Huazhong University of Science and Technology |
| NCT05886205 | Early Phase 1 (Phase 1) | Jun 5, 2023 | Beijing Konruns Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences |
| NCT05647213 | Phase 1 | Jan 31, 2023 | HeartWorks, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 2 | 2 | 2024 |
| Beijing Konruns Pharmaceutical Co., Ltd. | For profit | 1 | 0 | 1 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2023 |
| HeartWorks, Inc. | Academic/Hospital | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1